How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?

This study aimed to: (1) estimate the disease burden of herpes zoster (HZ) and (2) assess the potential public health impact of introducing adjuvanted recombinant zoster vaccine (RZV) compared with no vaccination in adults aged ≥50 years in Argentina, Brazil, Mexico, Chile, and Colombia using the ZO...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ru, Gomez, Jorge A., de Veras, Bruna, Pinto, Thatiana, Guzman-Holst, Adriana, Nieto, Javier, van Oorschot, Désirée A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Zoster
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026900/
https://www.ncbi.nlm.nih.gov/pubmed/36821856
http://dx.doi.org/10.1080/21645515.2022.2164144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026900/
https://www.ncbi.nlm.nih.gov/pubmed/36821856
http://dx.doi.org/10.1080/21645515.2022.2164144

Ejemplares similares